Treatment of metastatic renal cell carcinoma with low-dose interleukin-2

被引：0
|
作者：
Takezawa, Yuta [1 ]
Izumi, Kouji [1 ]
Nohara, Takahiro [1 ]
Narimoto, Kazutaka [1 ]
Ueno, Satoru [1 ]
Kadono, Yoshihumi [1 ]
Kitagawa, Yasuhide [1 ]
Konaka, Hiroyuki [1 ]
Mizokami, Atsushi [1 ]
Namiki, Mikio [1 ]
机构：
[1] Kanazawa Univ, Dept Urol, Kanazawa, Ishikawa 9201192, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-6-8
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [41] REGRESSION OF METASTATIC RENAL-CELL CARCINOMA FOLLOWING ADMINISTRATION OF PERIODATE-LYMPHOKINE ACTIVATED AUTOLOGOUS LEUKOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2
    WANG, J
    WALLE, A
    GORDON, B
    NOVOGRODSKY, A
    SUTHANTHIRAN, M
    RUBIN, AL
    STENZEL, KH
    CLINICAL RESEARCH, 1987, 35 (03): : A529 - A529
  • [42] High-Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma and Metastatic Melanoma: Still the Standard
    Dutcher, Janice P.
    ONCOLOGY-NEW YORK, 2011, 25 (05): : 427 - 428
  • [43] LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
    WERSALL, JP
    MASUCCI, G
    HJELM, AL
    RAGNHAMMAR, P
    FAGERBERG, J
    FRODIN, JE
    MERK, K
    LINDEMALM, C
    ERICSON, K
    KALIN, B
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (03): : 103 - 111
  • [44] EUROPEAN STUDIES OF INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA
    ATZPODIEN, J
    KIRCHNER, H
    HANNINEN, EL
    KORFER, A
    FENNER, M
    MENZEL, T
    DECKERT, M
    FRANZKE, A
    JONAS, U
    POLIWODA, H
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 22 - 26
  • [45] Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma
    Donskov, Frede
    DANISH MEDICAL BULLETIN, 2007, 54 (04) : 249 - 265
  • [46] Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2
    Gill, David M.
    Stenehjem, David D.
    Parikh, Kinjal
    Merriman, Joseph
    Sendilnathan, Arun
    Agarwal, Archana M.
    Hahn, Andrew W.
    Gupta, Sumati
    Tantravahi, Srinivas Kiran
    Samlowski, Wolfram E.
    Agarwal, Neeraj
    ECANCERMEDICALSCIENCE, 2016, 10
  • [47] SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA (VOL 69, PG 1111, 1994)
    RAVAUD
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1284 - 1284
  • [48] High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis
    Brusky, JP
    Gailani, F
    Pathak, A
    Patel, H
    Aboseif, S
    BJU INTERNATIONAL, 2006, 97 (02) : 279 - 280
  • [49] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [50] PHASE-II STUDY OF LOW-DOSE CYCLOPHOSPHAMIDE AND INTRAVENOUS INTERLEUKIN-2 IN METASTATIC RENAL-CANCER
    QUAN, WDY
    DEAN, GE
    LIESKOVSKY, G
    MITCHELL, MS
    KEMPF, RA
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 35 - 39
12345